License and Supply Agreement with Thermo Fisher Scientific signed at Macrogen headquarters Further development of the global CES market expected by expanding Macrogen’s “Genome Supermarket” strategy Kap-Seok Yang, CEO of Macrogen (KOSDAQ: 038290), announced on January 13 that the company has signed a strategic License and Supply Agreement with Thermo Fisher Scientific. The agreement, which was recently […]
Bolton, Massachusetts — In recognition of the growing demand for hyperspectral imaging products, Headwall and Ocean Insight have entered into a partnership agreement whereby Ocean Insight China will distribute Headwall’s products through the company’s extensive commercial channels in the region. The agreement is effective immediately and reflects the growing demand both companies see for spectral […]
DUBLIN, Ireland: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced the signing of a license agreement with Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan. The agreement provides Daiichi Sankyo with access to CRISPR/Cas9 genome editing technology […]
CO2Meter partners with Micro-Hybrid Electronic GmbH to offer best in class CO2 sensor for incubation. CO2Meter Inc., a leading, worldwide manufacturer of high-quality gas detection and monitoring solutions, has released a new CO2 Sensor for incubators that monitors and controls the environments for cell cultures, tissue samples, and bacteria growth patterns. The highly anticipated CO2 Incubator […]
Siena, Italy and Nottingham, UK – Exosomics SpA, the leading extracellular vesicles biotech company, today announced that it has implemented NanoFCM Co., Ltd’s NanoAnalyzer instrument to offer sophisticated contract research and measurement services worldwide. In this strategic partnership, Exosomics becomes NanoFCM’s approved service supplier of nano-flow cytometry measurements. These can be performed as stand-alone or […]
Lebanon, New Hampshire – Avitide Inc., the industry leader in the discovery and development of custom affinity purification resins, announce a partnership expansion with Allergan. Under the terms of the agreement, Avitide will use its proprietary affinity chromatography discovery, development, and supply platform for programs defined by Allergan. “The expansion of our partnership with Allergan […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year, non-exclusive collaboration agreement to broaden the adoption of distributable next-generation sequencing-based (NGS) testing in oncology. As the understanding of genomic drivers of cancer evolves, NGS has […]
Aims to develop the next generation of engineered CHO cell lines, to improve production of biotherapeutics Bioproduction is a key business unit within Horizon, this agreement underlines strategy to focus on core markets Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in the application of gene editing and […]
First Company Developing a KRAS(G12C) Inhibitor to Announce Multi-Platform Companion Diagnostics Collaborations With Guardant Health and QIAGEN Will Develop Blood- and Tissue-Based Companion Diagnostics For Investigational KRAS(G12C) Inhibitor AMG 510 KRAS G12C is Present in 13% of Non-Small Cell Lung Cancers With no Approved Targeted Treatments THOUSAND OAKS, Calif. — Amgen (NASDAQ: AMGN) today announced […]
Co-marketing partnership to drive awareness of ArcherDX IVD products and increase access to vital genomic information in the community oncology care setting Boulder, Colorado – ArcherDX, Inc. today announced a non-exclusive, multi-year partnership with Illumina, Inc. (NASDAQ: ILMN) intended to broaden access of next generation sequencing (NGS)-based oncology testing, including companion diagnostics for therapeutic selection, personalized […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
